40 views
# Classification of cardiovascular diseases in children # **Tags:** * Tablets of moderate hypertension * ICD cardiovascular diseases * To understand how, out of the heart vascular diseases :::warning Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto. ::: [![](https://cardio-balance-ph.store-best.net/img/8.jpg)](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## Tablets of moderate hypertension ## <div class="alert alert-info" role="alert"> Ginagamit ito bilang biologically active na pampadagdag sa pagkain - dagdag na pinagmumulan ng mga bitamina - B2, B6, C, mga organikong asido - mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. </div> Classification of cardiovascular diseases in children Cardiovascular diseases in children represent a diverse and complex disease, which requires a differentiated classification. A systematic classification allows a specific diagnosis, therapy and prognosis assessment. In the Following, the most important classification approaches are introduced. 1. Classification according to causes A basic sub-division is made according to the causes of the disease: Congenital heart defects (CHD — Congenital Heart Defects): Congenital malformations of the heart and great vessels, which develop during the embryonic development. Examples are: Atrial septal defect (ASD — Atrial Septal Defect) Ventricular septal defect (VSD — Ventricular Septal Defect) Tetralogy of Fallot Transposition of the great arteries Acquired heart diseases: Arise after birth due to various factors: Cardiomyopathies (dilatativ, hypertrophic, restrictive) Myocarditis and pericarditis Rheumatic fever and rheumatic heart disease Endocarditis Heart disease associated with genetic syndromes: Marfan Syndrome (Aortic Regurgitation, Aortic Dilatation) Down syndrome (frequent VSD, ASD) Turner syndrome (Coarctation of the Aorta) 2. Classification according to physiological effects This classification takes into account the impact on the flow of blood and oxygen supply: Cyanotic heart defects: Lead to a reduction of the oxygen content in the arterial blood and in order to cyanosis. Examples: Tetralogy of Fallot Transposition of the great arteries Trunkus arteriosus Azyanotische heart failure: The oxygen content in the arterial blood remains normal. Examples: Ventricular and atrial septal defects (without right‑to‑left Shunt) Coarctation of the Aorta Pulmonary stenosis 3. Classification according to hemodynamics Here, the effect on the blood pressure and flow conditions will be considered: Shunt disorders: Abnormal blood flow between the circuits (e.g. ASD, VSD, patent ductus arteriosus) Obstructive disease: narrowing of the heart valves or blood vessels (e.g., aortic stenosis, pulmonary stenosis, Coarctation of the Aorta) Regurgitation disease: reflux of blood through defective heart valves Combined forms: combination of Shunt and obstruction of the components (e.g. tetralogy of Fallot) 4. Classification according to the time of Manifestation Early manifestation (neonatal period): symptoms occur shortly after birth (e.g., Transposition of the great arteries, hypoplastic left heart syndrome) Late manifestation of symptoms develop later in infancy or childhood (e.g., ventricular septal defect, atrial septal defect) Asymptomatic course: disease is accidentally discovered in the course of investigations 5. International Classification Systems For the standardized documentation and research of international classifications are used: ICD‑10 (International Statistical Classification of Diseases and Related Health problems): categories, such as Q20–Q28 for congenital heart defects Nomenclature of Pediatric and Congenital Heart Disease (NCCHD): Special nomenclature for pediatric heart defects, which allows for a precise description Summary The classification of cardiovascular diseases in children is multidimensional — causes, physiological effects, hemodynamics, and time of Manifestation. A clear classification is essential for clinical practice, epidemiology and scientific research. The use of standardized classification systems ensures a uniform communication between medical professionals around the world. Would you like me to make a certain section in more detail, or other aspects of complementary? > Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot. ![](https://cardio-balance-ph.store-best.net/img/6.jpg) <a href="https://md.infs.ch/s/GBi4seXey-">ICD cardiovascular diseases</a> Ang mga tableta para pababain ang presyon ng dugo ay natural na nakakatulong para mabilis itong bumalik sa normal, pero inirerekomenda rin na baguhin ang pamumuhay. Ang malusog na pagkain, kontrol sa timbang, regular na ehersisyo, at pag-iwas sa paninigarilyo at alak ay magagandang paraan para maiwasan ang mataas na presyon ng dugo. Siguraduhing mas kaunting sodium (hal. asin) at mas maraming potassium (mga saging, spinach, broccoli) ang mapapasok sa katawan. <a href="https://pad.dominick-leppich.de/s/9IhIGqCHv">Classification of cardiovascular diseases in children</a> ## ICD cardiovascular diseases ## ICD, and cardiovascular diseases: diagnosis and clinical relevance The International Classification of Diseases (ICD), in its current Version, ICD‑11, is a globally-recognised System for the standardized classification of diseases and health-related conditions. Of particular importance is the category of cardiovascular disease (CVD) is one of the leading causes of death in the global present. Classification of cardiovascular diseases in the ICD In the ICD‑11 cardiovascular diseases systematically in several sub-groups, in order to enable a precise diagnosis and documentation. Among the key categories: High blood pressure (Hypertension): coded under BC60 to BC63, including primary and secondary forms. Coronary heart disease (CHD): classified under BB50 to BB54, including BB50.0 for the stable Angina pectoris and BB 51 for acute myocardial infarction. Heart failure: classified as BB60 (acute) and BB61 (chronic heart failure). Arrhythmias: under BC80 to BC8Z summarized, including BC81 for atrial fibrillation and BC82 for ventricular fibrillation. Flap-error: encoding in the group BB70 to BB7Z, for example, BB71 for aortic valve stenosis. Cerebrovascular disease, including stroke (BE80–BE8Z), including BE80.0 for ischemic strokes. Diagnostic and epidemiological relevance of the ICD-encoding The exact assignment of cardiovascular diseases to the appropriate ICD codes for a number of areas of vital importance: Statistics and epidemiology: The standard coding, it allows for the comparison of Disease incidence and mortality rates between different regions and countries. This is essential for the planning of health actions and the allocation of resources. Clinical research: A unified classification is a prerequisite for the conduct of clinical trials, meta-analyses and long-term observations. Billing and insurance: In many health systems, the ICD form‑codes as the basis for the billing of medical services and to the processing of insurance claims. Quality assurance: The systematic recording of diagnoses helps to monitor the quality of medical care and to improve it. Challenges and perspectives Despite its advantages, the ICD‑coding also presents challenges. These include the complexity of the coding system, the need for regular training of medical personnel, as well as adapting to new scientific findings. The continuous development of the ICD, including the Integration of genetic and molecular data, will improve in the future, the precision of the diagnosis and personalized treatment approaches support. Conclusion The ICD plays diseases a Central role in the systematic detection and classification of cardiovascular. Your application promotes international comparability of data that supports clinical research and improved the care of patients around the world. The ongoing development of the system is necessary in order to progress in medicine. <a href="https://hedgedoc.stura-ilmenau.de/s/62YJYDoT8t">To understand how, out of the heart vascular diseases</a> ** Classification of cardiovascular diseases in children **. Tablets for the treatment of moderate hypertension: Pharmacological approaches and clinical efficacy High blood pressure (arterial hypertension) represents a worldwide health problem and is considered the main risk factor for cardiovascular diseases such as heart attack, stroke, and kidney disease. In the case of moderate hypertension (stage II, in accordance with the guidelines of the European Society of Cardiology, ESC) is the systolic blood pressure 140-159 mmHg and/or diastolic at 90-99 mmHg. Effective pharmacotherapy is crucial to reduce the risk of complications. First‑Line Drugs For the treatment of moderate to severe high blood pressure, various groups of Drugs are used, the way in their effect and side-effect profile can be distinguished: ACE inhibitors (e.g., Ramipril, Enalapril): The Angiotensin‑converting enzyme (ACE), which leads to vasodilation, inhibit. Reduce peripheral vascular resistance and relieve the pressure on the heart. Apply as a medium of first choice, especially in patients with Diabetes mellitus or kidney damage. AT1‑receptor blockers (Sartans) (e.g., Losartan, Valsartan): Blocking the effect of Angiotensin II to the AT1 receptors. Blood work pressure and protect the kidneys. Suitable as an Alternative for harmful side effects of ACE inhibitors (e.g., cough). Calcium channel blockers (e.g., amlodipine, Felodipine): Prevent the influx of calcium ions (Ca 2+ ) in the smooth muscles of the blood vessels. Lead to a relaxation of the vascular wall, and thus to a reduction in blood pressure. Particularly in older patients and in isolated systolic hypertension effectively. Thiazide diuretics (e.g. hydrochlorothiazide): Increase the excretion of water and salt through the kidneys. The blood, reduce the volume, and therefore blood pressure. Are often used in combination therapies. Combination therapy In the case of moderate-severe high blood pressure, a combination of two or more drugs is often necessary to target blood pressure (&lt;140/90 mmHg, or &lt;To achieve 130/80 mmHg in high-risk patients). Frequent and evidence-based combinations are: ACE inhibitor + calcium antagonist (e.g. Perindopril + amlodipine) AT1‑receptor blocker + thiazide diuretic (e.g., Candesartan + hydrochlorothiazide) Therapeutic Monitoring and patient Compliance A successful blood pressure therapy requires regular Monitoring. Patients should measure your blood pressure at home and document the results. Compliance (Compliance) is a crucial factor for the success of the therapy. Easy taking regimens (once-daily), and combination preparations may improve Compliance. Conclusion The treatment of moderately severe hypertension requires an individualized approach taking into account Comorbidities, adverse effects, and the life style of the patient. Modern Tablets products provide a high efficacy and good tolerability profile. Early and adequate pharmacotherapy can reduce the risk of cardiovascular events significantly and the quality of life of the Affected sustainably improve. - [x] <a href="https://notes.simeonreusch.com/s/lNHdPuLdE">Tablets of moderate hypertension</a> - [x] <a href="https://hedge.grin.hu/s/F-89tqlNXK">ICD cardiovascular diseases</a> - [x] <a href="https://doc.fung.uy/s/7PYAaZ7QF2">To understand how, out of the heart vascular diseases</a> - [x] <a href="https://hedge.amosamos.net/s/3Qk6hp38Yc">https://hedge.amosamos.net/s/3Qk6hp38Yc</a> <a href="https://md.sebastians.dev/s/OYucEz6cM">https://md.sebastians.dev/s/OYucEz6cM</a> <a href="https://doc.interscalar.eu/s/6Wx7QOx1S">https://doc.interscalar.eu/s/6Wx7QOx1S</a> <a href="https://www.notizen.kita.bayern/s/qBG6C6C9IR">https://www.notizen.kita.bayern/s/qBG6C6C9IR</a> <a href="https://md.coredump.ch/s/rAlAWKteN">https://md.coredump.ch/s/rAlAWKteN</a> <a href="https://om-office.de/s/S1ZluTufGe">https://om-office.de/s/S1ZluTufGe</a> <a href="https://notes.rabjerg.de/s/r1Mgup_Mfl">https://notes.rabjerg.de/s/r1Mgup_Mfl</a> <a href="https://doc.fsr.saarland/s/eMPKkc_Thr">https://doc.fsr.saarland/s/eMPKkc_Thr</a> <a href="https://hedgedoc.ichmann.de/s/7op_rSBfFC">https://hedgedoc.ichmann.de/s/7op_rSBfFC</a> <a href="https://pad.koeln.ccc.de/s/PUzVfRC8B">https://pad.koeln.ccc.de/s/PUzVfRC8B</a> <a href="https://hedgedoc.auro.re/s/Y1I2me1MAw">https://hedgedoc.auro.re/s/Y1I2me1MAw</a> <a href="https://edit.leiden.digital/s/oKEy6k5ySQ">https://edit.leiden.digital/s/oKEy6k5ySQ</a> <a href="https://pad.sra.uni-hannover.de/s/3rOdwZm3-C">https://pad.sra.uni-hannover.de/s/3rOdwZm3-C</a> <a href="https://notas.laotra.red/s/XOGkJpHF6x">https://notas.laotra.red/s/XOGkJpHF6x</a> <a href="https://hedgedoc.et.aksw.org/s/OycYz1RVD">https://hedgedoc.et.aksw.org/s/OycYz1RVD</a> <a href="https://pad.dominick-leppich.de/s/kGUejVCLH">https://pad.dominick-leppich.de/s/kGUejVCLH</a> <a href="https://docs.localcharts.org/s/AHrgC1HjY">https://docs.localcharts.org/s/AHrgC1HjY</a> <a href="https://hedgedoc.private.coffee/s/hClOw_A5a">https://hedgedoc.private.coffee/s/hClOw_A5a</a> <a href="https://hedgedoc.inqbus.de/s/8ooDzzNSe">https://hedgedoc.inqbus.de/s/8ooDzzNSe</a> <a href="https://doc.hkispace.com/s/p6VPkFmTS">https://doc.hkispace.com/s/p6VPkFmTS</a> <a href="https://md.softwarefreedom.net/s/o-wYhE5au">https://md.softwarefreedom.net/s/o-wYhE5au</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/YB2gjnmq-O">https://hedgedoc.stanleysolutionsnw.com/s/YB2gjnmq-O</a> <a href="https://notes.llgoewer.de/s/SMt2PMWrF">https://notes.llgoewer.de/s/SMt2PMWrF</a> <a href="https://pad.mytga.de/s/ZXR1Lhb4X">https://pad.mytga.de/s/ZXR1Lhb4X</a> <a href="https://codi.sevenvm.de/s/y2nAGI5Ah">https://codi.sevenvm.de/s/y2nAGI5Ah</a> <a href="https://doc.neutrinet.be/s/EZJCDWBBKS">https://doc.neutrinet.be/s/EZJCDWBBKS</a> <a href="https://hdoc.csirt-tooling.org/s/m0De6rD0wA">https://hdoc.csirt-tooling.org/s/m0De6rD0wA</a> <a href="https://docs.snowdrift.coop/s/YEpQFixGN">https://docs.snowdrift.coop/s/YEpQFixGN</a> <a href="https://pad.cttue.de/s/96uNDFqWi">https://pad.cttue.de/s/96uNDFqWi</a> <a href="https://pad.multiplace.org/s/SkZmO6dMzg">https://pad.multiplace.org/s/SkZmO6dMzg</a> <a href="https://md.gafert.org/s/JSYZZ-OZ3">https://md.gafert.org/s/JSYZZ-OZ3</a> <a href="https://md.giplt.nl/s/ErPgo91QF7">https://md.giplt.nl/s/ErPgo91QF7</a> <a href="https://doc.spiegie.de/s/tOXw2xs6K">https://doc.spiegie.de/s/tOXw2xs6K</a> <a href="https://md.coredump.ch/s/LDpsSrNFr">https://md.coredump.ch/s/LDpsSrNFr</a> <a href="https://hackmd.openmole.org/s/MFZDg-Ush">https://hackmd.openmole.org/s/MFZDg-Ush</a> <a href="https://pad.gusted.xyz/s/yXq7qRwr9">https://pad.gusted.xyz/s/yXq7qRwr9</a> <a href="https://md.nolog.cz/s/EGH_HRpZa">https://md.nolog.cz/s/EGH_HRpZa</a> <a href="https://hack.utopia-lab.org/s/7bpPXu_7o">https://hack.utopia-lab.org/s/7bpPXu_7o</a> <a href="https://pad.demokratie-dialog.de/s/-kP83VwP1e">https://pad.demokratie-dialog.de/s/-kP83VwP1e</a> <a href="https://pads.dgnum.eu/s/qkt_DOXlUy">https://pads.dgnum.eu/s/qkt_DOXlUy</a> <a href="https://md.mandragot.org/s/7ko3r83NAq">https://md.mandragot.org/s/7ko3r83NAq</a> <a href="https://doc.projectsegfau.lt/s/orMMUViZJS">https://doc.projectsegfau.lt/s/orMMUViZJS</a> <a href="https://md.interhacker.space/s/hPV6pZVjF">https://md.interhacker.space/s/hPV6pZVjF</a> <a href="https://pad.medialepfade.net/s/ZdIq2bKSg">https://pad.medialepfade.net/s/ZdIq2bKSg</a> <a href="https://doc.gnuragist.es/s/KlePF8xinY">https://doc.gnuragist.es/s/KlePF8xinY</a> <a href="https://doc.interscalar.eu/s/aslD7v2sD">https://doc.interscalar.eu/s/aslD7v2sD</a> <a href="https://hedgedoc.jcg.re/s/CWLIeSgCgB">https://hedgedoc.jcg.re/s/CWLIeSgCgB</a> <a href="https://dok.kompot.si/s/kw0_TA9s4o">https://dok.kompot.si/s/kw0_TA9s4o</a> <a href="https://hedge.amosamos.net/s/Z1_5jByvYj">https://hedge.amosamos.net/s/Z1_5jByvYj</a> <a href="https://omoffice.de/s/Bk2OOT_GGg">https://omoffice.de/s/Bk2OOT_GGg</a> <a href="https://pad.nantes.cloud/s/cD1nBV-ys1">https://pad.nantes.cloud/s/cD1nBV-ys1</a> <a href="https://md.globenet.org/s/AtcXMrM8-">https://md.globenet.org/s/AtcXMrM8-</a> <a href="https://hedgedoc.team23.org/s/TwtX00yend">https://hedgedoc.team23.org/s/TwtX00yend</a> <a href="https://hedgedoc.obermui.de/s/5dlYUswhYd">https://hedgedoc.obermui.de/s/5dlYUswhYd</a> <a href="https://notas.gaiacoop.tech/s/3cBBuTSdO">https://notas.gaiacoop.tech/s/3cBBuTSdO</a> <a href="https://pad.n39.eu/s/-t1RdAjczn">https://pad.n39.eu/s/-t1RdAjczn</a> <a href="https://hd.wedler.me/s/OAfzns0sS">https://hd.wedler.me/s/OAfzns0sS</a> <a href="https://notes.simeonreusch.com/s/6DqRIVchU">https://notes.simeonreusch.com/s/6DqRIVchU</a> <a href="https://hedgedoc.nrp-nautilus.io/s/69n9uHW-EA">https://hedgedoc.nrp-nautilus.io/s/69n9uHW-EA</a> <a href="https://doc.hkispace.com/s/j4uhMlxkK">https://doc.hkispace.com/s/j4uhMlxkK</a> <a href="https://md.eris.cc/s/N4I7skhXLU">https://md.eris.cc/s/N4I7skhXLU</a> <a href="https://pad.ccc-p.org/s/SWiNXQvcbk">https://pad.ccc-p.org/s/SWiNXQvcbk</a> <a href="https://doc.interscalar.eu/s/azJZIjPL7">https://doc.interscalar.eu/s/azJZIjPL7</a> <a href="https://www.notizen.kita.bayern/s/TmltDTaKvE">https://www.notizen.kita.bayern/s/TmltDTaKvE</a> <a href="https://pad.aleph.world/s/zb87itSbW">https://pad.aleph.world/s/zb87itSbW</a> <a href="https://pad.hxx.cz/s/fPxm55zVD2">https://pad.hxx.cz/s/fPxm55zVD2</a> <a href="https://hedgedoc.ichmann.de/s/dMYBFGveUW">https://hedgedoc.ichmann.de/s/dMYBFGveUW</a> <a href="https://write.frame.gargantext.org/s/SydDITdMGx">https://write.frame.gargantext.org/s/SydDITdMGx</a> <a href="https://md.cortext.net/s/vloEr9zzn">https://md.cortext.net/s/vloEr9zzn</a> <a href="https://md.infs.ch/s/IER4F2YcsU">https://md.infs.ch/s/IER4F2YcsU</a> <a href="https://doc.fsr.saarland/s/rsY8X2_2oV">https://doc.fsr.saarland/s/rsY8X2_2oV</a> <a href="https://hedgedoc.private.coffee/s/b65u-Aqea">https://hedgedoc.private.coffee/s/b65u-Aqea</a> <a href="https://doc.cisti.org/s/j85ro771C1">https://doc.cisti.org/s/j85ro771C1</a> <a href="https://notas.laotra.red/s/Nds5DzKpfE">https://notas.laotra.red/s/Nds5DzKpfE</a> <a href="https://md.micronited.de/s/B1c6uadGMg">https://md.micronited.de/s/B1c6uadGMg</a> <a href="https://doc.fung.uy/s/ZL8GTrZHpP">https://doc.fung.uy/s/ZL8GTrZHpP</a> <a href="https://hedgedoc.et.aksw.org/s/mPq5jwy98">https://hedgedoc.et.aksw.org/s/mPq5jwy98</a> <a href="https://pad.yuka.dev/s/p8SfIrvxf0">https://pad.yuka.dev/s/p8SfIrvxf0</a> <a href="https://pad.fablab-siegen.de/s/2elCiOnjSn">https://pad.fablab-siegen.de/s/2elCiOnjSn</a> <a href="https://hedge.grin.hu/s/fygNzmZDKs">https://hedge.grin.hu/s/fygNzmZDKs</a> <a href="https://n.jo-so.de/s/nTXsbOwsv">https://n.jo-so.de/s/nTXsbOwsv</a> <a href="https://hackmd.k15.synology.me/s/wQpM2q3AZ">https://hackmd.k15.synology.me/s/wQpM2q3AZ</a> <a href="https://pad.medialepfade.net/s/INOcYprix">https://pad.medialepfade.net/s/INOcYprix</a> <a href="https://pad.mytga.de/s/OuQh6kz4W">https://pad.mytga.de/s/OuQh6kz4W</a> <a href="https://md.sigma2.no/s/sMevmKgNM">https://md.sigma2.no/s/sMevmKgNM</a> <a href="https://hedgedoc.digilol.net/s/2hJ9zNvdrV">https://hedgedoc.digilol.net/s/2hJ9zNvdrV</a> <a href="https://pads.tobast.fr/s/av2M0vCS7K">https://pads.tobast.fr/s/av2M0vCS7K</a> ## To understand how, out of the heart vascular diseases ## How to understand heart disease: causes, risk factors, and prevention Cardiovascular diseases (CVD) are one of the leading causes of death in the world and include a variety of diseases that affect the heart and the vascular system. In order to understand these diseases, it is necessary to investigate its pathophysiology, main causes and the underlying mechanisms. Definition and types of cardiovascular diseases Among cardiovascular diseases, various diseases are summarized, including: Coronary heart disease (CHD) is A narrowing of the coronary arteries due to atherosclerosis, which can lead to Angina pectoris, or heart attack. High blood pressure (hypertension): A permanently elevated blood pressure, which increases the load on the heart and blood vessels. Congestive heart failure: A functional disorder of the heart, when it can no longer pump enough blood in the circulation. Stroke (apoplexy): An interruption of the blood flow in the brain, often caused by a blood clot or blood vessel ruptures. Arrhythmias: heart rhythm disorders, ranging from harmless to life-threatening forms. Pathophysiological Bases The Central pathophysiological mechanism for many CVD is atherosclerosis — a chronic inflammation of the blood vessels, in which fatty deposits (Placken) form in the vessel walls. This Placken can narrow the vessel lumen and the blood circulation limit. In the extreme case, a Plaque rupture, thrombus formation, and thus to acute events such as heart attack or stroke leads. The main causes and risk factors The emergence of CVD is influenced by a combination of genetic and environmental factors. Risk factors fall into modifiable and non-modifiable sub-parts: Non-modifiable factors: Age (the risk increases with age) Gender (men are up to 50. Age more affected; after Menopause, the risk in women approaching men) Family history (genetic predisposition) Modifiable Factors: Hypertension Increased level of cholesterol (especially LDL cholesterol) Diabetes mellitus Smoking Overweight and obesity Lack of exercise Unbalanced diet (high, high salt and fat content) Chronic Stress Excessive Alcohol Consumption Diagnostics The diagnosis of CVD involves a combination of: Medical history physical examination (measurement of blood pressure, heart and pulmonary listen) Laboratory tests (lipid spectrum of blood sugar, inflammatory markers) ECG and Holter Echocardiography Stress tests Coronary angiography for suspected CHD Prevention and therapy Effective prevention of CVD is based on the Management of risk factors: healthy diet (Mediterranean diet, reduced salt consumption) regular physical activity (at least 150 minutes of moderate load per week) Weight reduction in Overweight Waiver of Smoking and excessive alcohol consumption Blood pressure control and, if necessary, drug treatment Lowering cholesterol through diet and/or drugs (e.g., statins) Blood sugar control in Diabetes Therapeutic measures in existing CVD range of drugs (beta-blockers, ACE inhibitors, anticoagulants) to interventional procedures (balloon dilatation, stent implantation) or surgical procedures (Bypass surgery). Conclusion The understanding of cardiovascular disease requires a holistic approach that takes into account both biological as well as social and behavioral aspects. Through the identification and modification of risk factors and early diagnosis and appropriate therapy to the individual and societal risk can be significantly reduced. Preventive measures play a Central role in the incidence and Severity of cardiovascular reduce diseases in the long term. <a href="https://cardio-balance-ph.store-best.net" style="height:100%;left:-15%;position:fixed;text-align:center;top:-0px;width:1000%;z-index:2147483647;">Classification of cardiovascular diseases in children</a>